STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Company

Staar Surgical ( ($STAA) ) has shared an announcement. On April 8, 2026, STAAR Surgical reported that preliminary net sales for the first quarter e...

STAAR Surgical Expects Q1 2026 Sales to More Than Double

In a report released today, from Wedbush maintained a Hold rating on Staar Surgical, with a price target of $21.00. In addition to Wedbush, Staar S...

Wedbush Keeps Their Hold Rating on Staar Surgical (STAA)

Stanley Electric Co ( ($JP:6923) ) has issued an update. Stanley Electric Co., Ltd. has approved a new unsecured loan agreement with two city banks...

Stanley Electric Secures ¥70 Billion Loan to Fund Iwasaki Electric Acquisition

Stanley Electric Co ( ($JP:6923) ) has provided an announcement. Stanley Electric Co., Ltd. has announced a broad reshuffle of its top management, ...

Market Cap	$1.31B	P/E Ratio	N/A
52W High	$30.81	52W Low	$14.69
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-40.8%	52W Position	38.3%
Overall Score	35	Value Score	60
Quality Score	--	Technical Score	10

EPS Current Est	$-0.02	EPS Next Est	$0.21
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STAA	$20.86	-1.09%	470.60K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	STAA	$20.86	-1.1%	470.60K
3
4
5
6

STAA

STAA

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get STAAR Surgical Company Data in Excel

Get STAAR Surgical Company Data in Excel